• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用卷积神经网络在钆塞酸二钠增强磁共振成像的肝胆期进行计算机辅助肝细胞癌检测:多序列数据的可行性评估

Computer-aided hepatocellular carcinoma detection on the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging using a convolutional neural network: Feasibility evaluation with multi-sequence data.

作者信息

Cho Yongwon, Han Yeo Eun, Kim Min Ju, Park Beom Jin, Sim Ki Choon, Sung Deuk Jae, Han Na Yeon, Park Yang Shin

机构信息

Department of Radiology, Korea University Anam Hospital, Korea University College of Medicine, 73, Goryeodae-ro, Seongbuk-gu, Seoul 02841, Republic of Korea; AI Center, Korea University Anam Hospital, Korea University College of Medicine, 73, Goryeodae-ro, Seongbuk-gu, Seoul 02841, Republic of Korea.

Department of Radiology, Korea University Anam Hospital, Korea University College of Medicine, 73, Goryeodae-ro, Seongbuk-gu, Seoul 02841, Republic of Korea.

出版信息

Comput Methods Programs Biomed. 2022 Oct;225:107032. doi: 10.1016/j.cmpb.2022.107032. Epub 2022 Jul 20.

DOI:10.1016/j.cmpb.2022.107032
PMID:35930863
Abstract

BACKGROUND AND OBJECTIVES

Diagnosis of hepatocellular carcinoma (HCC) on liver MRI needs analysis of multi-sequence images. However, developing computer-aided detection (CAD) for every single sequence requires considerable time and labor for image segmentation. Therefore, we developed CAD for HCC on the hepatobiliary phase (HBP) of gadoxetic acid-enhanced magnetic resonance imaging (MRI) using a convolutional neural network (CNN) and evaluated its feasibility on multi-sequence, multi-unit, and multi-center data.

METHODS

Patients who underwent gadoxetic acid-enhanced MRI and surgery for HCC in Korea University Anam Hospital (KUAH) and Korea University Guro Hospital (KUGH) were reviewed. Finally, 170 nodules from 155 consecutive patients from KUAH and 28 nodules from 28 patients randomly selected from KUGH were included. Regions of interests were drawn on the whole HCC volume on HBP, T1-weighted (T1WI), T2-weighted (T2WI), and portal venous phase (PVP) images. The CAD was developed from the HBP images of KUAH using customized-nnUNet and post-processed for false-positive reduction. Internal and external validation of the CAD was performed with HBP, T1WI, T2WI, and PVP of KUAH and KUGH.

RESULTS

The figure of merit and recall of the jackknife alternative free-response receiver operating characteristic of the CAD for HBP, T1WI, T2WI, and PVP at false-positive rate 0.5 were (0.87 and 87.0), (0.73 and 73.3), (0.13 and 13.3), and (0.67 and 66.7) in KUAH and (0.86 and 86.0), (0.61 and 53.6), (0.07 and 0.07), and (0.57 and 53.6) in KUGH, respectively.

CONCLUSIONS

The CAD for HCC on gadoxetic acid-enhanced MRI developed by CNN from HBP detected HCCs feasibly on HBP, T1WI, and PVP of gadoxetic acid-enhanced MRI obtained from multiple units and centers. This result imply that the CAD developed using single MRI sequence may be applied to other similar sequences and this will reduce labor and time for CAD development in multi-sequence MRI.

摘要

背景与目的

肝脏磁共振成像(MRI)上肝细胞癌(HCC)的诊断需要对多序列图像进行分析。然而,为每个单独序列开发计算机辅助检测(CAD)需要花费大量时间和人力进行图像分割。因此,我们使用卷积神经网络(CNN)开发了基于钆塞酸增强磁共振成像(MRI)肝胆期(HBP)的HCC计算机辅助检测方法,并在多序列、多机构和多中心数据上评估了其可行性。

方法

回顾了在韩国大学安岩医院(KUAH)和韩国大学九老医院(KUGH)接受钆塞酸增强MRI检查并接受HCC手术的患者。最后,纳入了KUAH连续155例患者的170个结节以及从KUGH随机选取的28例患者的28个结节。在HBP、T1加权(T1WI)、T2加权(T2WI)和门静脉期(PVP)图像上的整个HCC体积上绘制感兴趣区域。使用定制的nnUNet从KUAH的HBP图像开发CAD,并进行后处理以减少假阳性。使用KUAH和KUGH的HBP、T1WI、T2WI和PVP对CAD进行内部和外部验证。

结果

在KUAH中,CAD针对HBP、T1WI、T2WI和PVP在假阳性率为0.5时的留一法替代自由响应接收器操作特征的品质因数和召回率分别为(0.87和87.0)、(0.73和73.3)、(0.13和13.3)以及(0.67和66.7);在KUGH中分别为(0.86和86.0)、(0.61和53.6)、(0.07和0.07)以及(0.57和53.6)。

结论

由CNN从HBP开发的基于钆塞酸增强MRI的HCC CAD能够在从多个机构和中心获得的钆塞酸增强MRI的HBP、T1WI和PVP上可靠地检测HCC。这一结果表明,使用单一MRI序列开发的CAD可能适用于其他类似序列,这将减少多序列MRI中CAD开发的人力和时间。

相似文献

1
Computer-aided hepatocellular carcinoma detection on the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging using a convolutional neural network: Feasibility evaluation with multi-sequence data.使用卷积神经网络在钆塞酸二钠增强磁共振成像的肝胆期进行计算机辅助肝细胞癌检测:多序列数据的可行性评估
Comput Methods Programs Biomed. 2022 Oct;225:107032. doi: 10.1016/j.cmpb.2022.107032. Epub 2022 Jul 20.
2
Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.钆塞酸增强肝脏磁共振成像在检测 HCC 和根据米兰标准和 UNOS 指南分配肝移植受者中的诊断性能:与组织病理学发现的相关性。
Radiology. 2015 Jan;274(1):149-60. doi: 10.1148/radiol.14140141. Epub 2014 Sep 5.
3
Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.钆塞酸二钠增强肝脏磁共振成像上肝内肿块型胆管癌与肝细胞癌的鉴别诊断
Eur Radiol. 2016 Jun;26(6):1808-17. doi: 10.1007/s00330-015-4005-8. Epub 2015 Sep 15.
4
Semiautomated segmentation of hepatocellular carcinoma tumors with MRI using convolutional neural networks.使用卷积神经网络对 MRI 中的肝细胞癌肿瘤进行半自动分割。
Eur Radiol. 2023 Sep;33(9):6020-6032. doi: 10.1007/s00330-023-09613-0. Epub 2023 Apr 18.
5
Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis.添加肝胆期图像对磁共振成像检测肝细胞癌的性能:一项荟萃分析。
Eur Radiol. 2022 Nov;32(11):7883-7895. doi: 10.1007/s00330-022-08826-z. Epub 2022 May 17.
6
Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.钆塞酸增强磁共振成像及扩散加权成像在酒精性肝硬化患者中鉴别高血供增生结节与小(<3 cm)高血供肝细胞癌的价值:一项回顾性病例对照研究
J Magn Reson Imaging. 2020 Jan;51(1):70-80. doi: 10.1002/jmri.26768. Epub 2019 May 6.
7
Suboptimal hepatobiliary phase image in gadoxetic acid-enhanced liver MRI for the evaluation of the HCC: Predictive factors.钆塞酸增强肝脏 MRI 肝胆期图像质量不佳对 HCC 评估的影响因素分析。
Medicine (Baltimore). 2023 Nov 17;102(46):e36176. doi: 10.1097/MD.0000000000036176.
8
Characterizing Computed Tomography-Detected Arterial Hyperenhancing-Only Lesions in Patients at Risk of Hepatocellular Carcinoma: Can Non-Contrast Magnetic Resonance Imaging Be Used for Sequential Imaging?描述计算机断层扫描检测到的动脉高增强仅病变在肝细胞癌风险患者中的特征:非对比磁共振成像能否用于连续成像?
Korean J Radiol. 2020 Mar;21(3):280-289. doi: 10.3348/kjr.2019.0447.
9
Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients.肝胆期钆塞酸增强 MRI 对高危患者肝细胞癌诊断的附加价值。
World J Gastroenterol. 2013 Dec 7;19(45):8357-65. doi: 10.3748/wjg.v19.i45.8357.
10
Application of a deep learning algorithm for three-dimensional T1-weighted gradient-echo imaging of gadoxetic acid-enhanced MRI in patients at a high risk of hepatocellular carcinoma.深度学习算法在钆塞酸增强 MRI 三维 T1 加权梯度回波成像中对高危肝细胞癌患者的应用。
Abdom Radiol (NY). 2024 Mar;49(3):738-747. doi: 10.1007/s00261-023-04124-4. Epub 2023 Dec 14.

引用本文的文献

1
Artificial intelligence in imaging diagnosis of liver tumors: current status and future prospects.人工智能在肝脏肿瘤影像诊断中的现状与未来展望
Abdom Radiol (NY). 2025 Jun 19. doi: 10.1007/s00261-025-05059-8.
2
Application of artificial intelligence in the diagnosis of hepatocellular carcinoma.人工智能在肝细胞癌诊断中的应用。
eGastroenterology. 2023 Nov 30;1(2):e100002. doi: 10.1136/egastro-2023-100002. eCollection 2023 Sep.
3
Application of dynamic enhanced scanning with GD-EOB-DTPA MRI based on deep learning algorithm for lesion diagnosis in liver cancer patients.
基于深度学习算法的Gd-EOB-DTPA磁共振成像动态增强扫描在肝癌患者病变诊断中的应用
Front Oncol. 2025 Jan 6;14:1423549. doi: 10.3389/fonc.2024.1423549. eCollection 2024.
4
Normalization Strategies in Multi-Center Radiomics Abdominal MRI: Systematic Review and Meta-Analyses.多中心腹部MRI影像组学中的标准化策略:系统评价与荟萃分析
IEEE Open J Eng Med Biol. 2023 Apr 28;4:67-76. doi: 10.1109/OJEMB.2023.3271455. eCollection 2023.